It is a modular urinalysis workflow launched by DIRUI, which can meet the realistic needs of clinical laboratories for automated and high-throughput urine testing.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

On December 13, COVID-19 specific medicine was available online. The COVID-19 Consultation Clinic at 111, Inc. Internet hospital has begun pre-selling Pfizer's COVID-19 oral antiviral drug Paxlovid (nematovir/ritonavir tablets), priced at CNY 2,980 per box.

A team from Stanford University, Columbia University, the New York Genome Center, and elsewhere has uncovered somatic tandem repeat expansions in tumors from a wide range of cancer types, including a potentially targetable repeat expansion in a subset of kidney cancers.

Thermo Fisher Scientific said on Wednesday that its monkeypox PCR test has been granted Emergency Use Authorization by the US Food and Drug Administration.

Bioinformatics company Envisagenics said Tuesday that it has formed a research collaboration with Queen Mary University of London and the technology-transfer arm of Cancer Research UK to explore the role of "alternative" splicing in hematopoietic cancer.

Agilent Technologies and Qiagen said on Monday and Tuesday respectively that they have gained US Food and Drug Administration approval of companion diagnostic assays for use with a new treatment for patients with advanced non-small cell lung cancer.

The government of Hong Kong has just announced that effective Wednesday, December 14th 2022, almost all restrictions for international travelers will be removed, which includes restrictions on movement and the issuance of the Amber (probation-like) health code via app.

The Hurun Research Institute today, in association with Jiaxing City in East China, released the 2022 Hurun Global 500, a list of the 500 most valuable non-state-controlled companies in the world.

Immune cell gene expression patterns and subtypes may hold clues to immune-related adverse effects (AEs) that cancer patients develop after immune checkpoint blockade immunotherapy (ICI), new research suggests.

Swiss firm 4D Lifetec said Monday it has forged a partnership with the Molecular Diagnostics Group to produce and automate 4D Lifetec's cancer assays and develop the tests for high-throughput screening.

The data shows that the current average daily sales volume of self-test boxes has increased by more than 400 times compared with November.